{"resourceType":"ValueSet","id":"adverse-event-clinical-research-grades","meta":{"profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset"]},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet adverse-event-clinical-research-grades</b></p><a name=\"adverse-event-clinical-research-grades\"> </a><a name=\"hcadverse-event-clinical-research-grades\"> </a><a name=\"adverse-event-clinical-research-grades-en-US\"> </a><ul><li>Include these codes as defined in <a href=\"CodeSystem-v3-nciThesaurus.html\"><code>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C41338</td><td>Grade 1 Mild Adverse Event</td></tr><tr><td>C41339</td><td>Grade 2 Moderate Adverse Event</td></tr><tr><td>C41340</td><td>Grade 3 Severe Adverse Event</td></tr><tr><td>C41337</td><td>Grade 4 Life Threatening or Disabling Adverse Event</td></tr><tr><td>C48275</td><td>Grade 5 Death Related to Adverse Event</td></tr></table></li></ul></div>"},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-wg","valueCode":"brr"},{"url":"http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm","valueInteger":1}],"url":"http://terminology.hl7.org/ValueSet/adverse-event-clinical-research-grades","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.11.21027"}],"version":"1.0.0","name":"AdverseEventClinicalResearchGrades","title":"Adverse Event Clinical Research Grades","status":"active","experimental":false,"date":"2023-07-28T19:27:19+00:00","publisher":"Health Level Seven International","contact":[{"telecom":[{"system":"url","value":"http://hl7.org"},{"system":"email","value":"hq@HL7.org"}]}],"description":"Value set of grades used in Adverse Event Clinical Research, especially in Oncology clinical trials","copyright":"This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html","compose":{"include":[{"system":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl","concept":[{"code":"C41338","display":"Grade 1 Mild Adverse Event"},{"code":"C41339","display":"Grade 2 Moderate Adverse Event"},{"code":"C41340","display":"Grade 3 Severe Adverse Event"},{"code":"C41337","display":"Grade 4 Life Threatening or Disabling Adverse Event"},{"code":"C48275","display":"Grade 5 Death Related to Adverse Event"}]}]}}